Philips's 3Q Margin Quells Concerns over Full-Year Delivery
Dow Jones11-03
0832 GMT - Philips' third-quarter margin result was a positive, as it helps allay concerns about full-year delivery, according to Natalia Webster at RBC Capital Markets. This will likely offset the Dutch health-technology company's less impressive diagnostics and treatment sales growth, though these factors will be front of mind for investors, she adds. Alongside this, investors and analysts will be focused on updates around the U.S. consent decree process, she adds. Shares rise 6.6%.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments